LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 44 filers reported holding LYRA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $241,000 | -22.5% | 60,000 | -15.9% | 0.00% | 0.0% |
| Q4 2021 | $311,000 | +6.5% | 71,313 | +122.8% | 0.00% | 0.0% |
| Q3 2021 | $292,000 | +52.9% | 32,014 | +34.5% | 0.00% | +50.0% |
| Q2 2021 | $191,000 | -30.8% | 23,800 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $276,000 | +1.8% | 23,800 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $271,000 | +1.9% | 23,800 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $266,000 | -1.5% | 23,800 | 0.0% | 0.00% | -40.0% |
| Q2 2020 | $270,000 | – | 23,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|